Can fecal microbiota transplantation cure irritable bowel syndrome?

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Can fecal microbiota transplantation cure irritable bowel syndrome? / Halkjær, Sofie Ingdam; Boolsen, Anders Watt; Günther, Stig; Christensen, Alice Højer; Petersen, Andreas Munk.

I: World Journal of Gastroenterology, Bind 23, Nr. 22, 14.06.2017, s. 4112-4120.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Halkjær, SI, Boolsen, AW, Günther, S, Christensen, AH & Petersen, AM 2017, 'Can fecal microbiota transplantation cure irritable bowel syndrome?', World Journal of Gastroenterology, bind 23, nr. 22, s. 4112-4120. https://doi.org/10.3748/wjg.v23.i22.4112

APA

Halkjær, S. I., Boolsen, A. W., Günther, S., Christensen, A. H., & Petersen, A. M. (2017). Can fecal microbiota transplantation cure irritable bowel syndrome? World Journal of Gastroenterology, 23(22), 4112-4120. https://doi.org/10.3748/wjg.v23.i22.4112

Vancouver

Halkjær SI, Boolsen AW, Günther S, Christensen AH, Petersen AM. Can fecal microbiota transplantation cure irritable bowel syndrome? World Journal of Gastroenterology. 2017 jun. 14;23(22):4112-4120. https://doi.org/10.3748/wjg.v23.i22.4112

Author

Halkjær, Sofie Ingdam ; Boolsen, Anders Watt ; Günther, Stig ; Christensen, Alice Højer ; Petersen, Andreas Munk. / Can fecal microbiota transplantation cure irritable bowel syndrome?. I: World Journal of Gastroenterology. 2017 ; Bind 23, Nr. 22. s. 4112-4120.

Bibtex

@article{b0722915ac274ad6a97212bdab9573b6,
title = "Can fecal microbiota transplantation cure irritable bowel syndrome?",
abstract = "AIM: To verify the utility of treatment with fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome (IBS).METHODS: We searched EMBASE, Cochrane Library and PubMed in March, 2017. The reviewed literature was based on two systematic searches in each of the databases. The MeSH terms used were IBS and fecal microbiota transplantation and the abbreviations IBS and FMT. Reference lists from the articles were reviewed to identify additional pertinent articles.RESULTS: A total of six conference abstracts, one case report, one letter to the editor, and one clinical review were included. In the final analysis, treatment of 48 patients was evaluated. Treatment revealed an improvement in 58% of cases. The varying structure of the nine included studies must be taken into consideration.CONCLUSION: Data on FMT and IBS are too limited to draw sufficient conclusions. Standardized double blinded randomized clinical trials need to be carried out to evaluate the effect of FMT on IBS.",
keywords = "Journal Article",
author = "Halkj{\ae}r, {Sofie Ingdam} and Boolsen, {Anders Watt} and Stig G{\"u}nther and Christensen, {Alice H{\o}jer} and Petersen, {Andreas Munk}",
year = "2017",
month = jun,
day = "14",
doi = "10.3748/wjg.v23.i22.4112",
language = "English",
volume = "23",
pages = "4112--4120",
journal = "World Chinese Journal of Digestology",
issn = "1009-3079",
publisher = "Baishideng Publishing Group Co., Limited",
number = "22",

}

RIS

TY - JOUR

T1 - Can fecal microbiota transplantation cure irritable bowel syndrome?

AU - Halkjær, Sofie Ingdam

AU - Boolsen, Anders Watt

AU - Günther, Stig

AU - Christensen, Alice Højer

AU - Petersen, Andreas Munk

PY - 2017/6/14

Y1 - 2017/6/14

N2 - AIM: To verify the utility of treatment with fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome (IBS).METHODS: We searched EMBASE, Cochrane Library and PubMed in March, 2017. The reviewed literature was based on two systematic searches in each of the databases. The MeSH terms used were IBS and fecal microbiota transplantation and the abbreviations IBS and FMT. Reference lists from the articles were reviewed to identify additional pertinent articles.RESULTS: A total of six conference abstracts, one case report, one letter to the editor, and one clinical review were included. In the final analysis, treatment of 48 patients was evaluated. Treatment revealed an improvement in 58% of cases. The varying structure of the nine included studies must be taken into consideration.CONCLUSION: Data on FMT and IBS are too limited to draw sufficient conclusions. Standardized double blinded randomized clinical trials need to be carried out to evaluate the effect of FMT on IBS.

AB - AIM: To verify the utility of treatment with fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome (IBS).METHODS: We searched EMBASE, Cochrane Library and PubMed in March, 2017. The reviewed literature was based on two systematic searches in each of the databases. The MeSH terms used were IBS and fecal microbiota transplantation and the abbreviations IBS and FMT. Reference lists from the articles were reviewed to identify additional pertinent articles.RESULTS: A total of six conference abstracts, one case report, one letter to the editor, and one clinical review were included. In the final analysis, treatment of 48 patients was evaluated. Treatment revealed an improvement in 58% of cases. The varying structure of the nine included studies must be taken into consideration.CONCLUSION: Data on FMT and IBS are too limited to draw sufficient conclusions. Standardized double blinded randomized clinical trials need to be carried out to evaluate the effect of FMT on IBS.

KW - Journal Article

U2 - 10.3748/wjg.v23.i22.4112

DO - 10.3748/wjg.v23.i22.4112

M3 - Journal article

C2 - 28652664

VL - 23

SP - 4112

EP - 4120

JO - World Chinese Journal of Digestology

JF - World Chinese Journal of Digestology

SN - 1009-3079

IS - 22

ER -

ID: 184876319